Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine
© Guo et al.; licensee BioMed Central Ltd. 2012
Received: 24 August 2012
Accepted: 13 October 2012
Published: 13 December 2012
Neointimal formation plays an important role in the pathogenesis of coronary restenosis after percutaneous coronary intervention (PCI), especially in patients with diabetes mellitus. Recently, some studies have shown that 5-ethynyl-2'-deoxyuridine (EdU) incorporation can serve as a novel alternative to the 5-bromo-2'-deoxyuridine (BrdU) antibody detection method for detection of DNA synthesis in regenerating avian cochlea, chick embryo and the adult nervous system. However, few studies have been performed to assess the suitability of EdU for detecting DNA synthesis in vascular neointima.
The carotid artery balloon injury model was established in Goto-Kakizaki (GK) and Wistar rats. A Cell-LightTM EdU Kit was used to detect EdU-labeled cell nuclei of common carotid arteries at day 7 after catheter balloon injury. Different methods of injecting EdU were tested. The protein levels of proliferating cell nuclear antigen (PCNA) and p-Akt (Ser473), as well as the mRNA levels of PCNA were evaluated by Western blotting and quantitative real-time PCR (qRT-PCR), respectively. Immunohistochemical staining was also employed to visualize PCNA-positive cells.
At day 7 after catheter balloon injury, far more EdU-positive and PCNA-positive cells were observed in GK rats. When comparing groups that received different EdU doses, it was found that the percentage of EdU-positive cells at a dose of 100 mg/kg body weight was than at doses of 25 mg/kg and 50 mg/kg. The number of positive cells was significantly higher in the repeated injection group compared to the single injection group. Further, after balloon injury DNA synthesis in GK rats was more notable than in Wistar rats. Neointimal formation in GK rats was more obvious than in Wistar rats. The protein levels of PCNA and p-Akt (Ser473) and the mRNA levels of PCNA were increased in injured rats as compared to uninjured rats, and were significantly higher in GK rats than in Wistar rats.
By intraperitoneal injections of EdU at a dose of 100 mg/kg three times, EdU incorporation can detect carotid arterial DNA synthesis caused by neointimal formation in GK rats and Wistar rats at day 7 after balloon injury by the EdU click reaction quickly and effectively. Moreover, more obvious DNA synthesis in the vascular neointima could be observed in GK rats than in Wistar rats.
KeywordsNeointimal formation DNA synthesis Diabetes mellitus EdU Catheter balloon injury PCNA
Coronary artery disease (CAD) is the leading cause of death among both men and women in China and western industrialized nations. Diabetes mellitus is the single worst risk factor for CAD. CAD in diabetic patients is diffuse, severe, presents with more complex lesions and often progresses rapidly. Restenosis remains the major limitation for long-term success after percutaneous coronary intervention (PCI) even in the drug eluting stent era, especially in patients with diabetes mellitus [1, 2]. Angiographic restenosis rates of 15.2% have been demonstrated following successful drug-eluting stenting among patients with diabetes in a study in Germany . Drug eluting stents are considered by many to be the standard of care for patients with diabetes undergoing PCI; however, analysis of diabetic subgroup in the SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) trial demonstrated that absolute late loss of lumen and restenosis remains higher in patients with diabetes receiving stents eluting sirolimus (also known as rapamycin, an immunosuppressive agent) . TAXUS (a brand of stent) trials showed similar results, in which the slow rate-release polymer-based stents eluting paclitaxel (an antineoplastic agent) were employed . Sheehy et al. found that the use of paclitaxel-eluting stents resulted in greater neointimal area and increased inflammation compared to everolimus-eluting stents . Thus, it is clear that the occurrence of restenosis still remains inevitable regardless which drug-eluting stent is employed. Generally, restenosis is the result of early elastic recoil, adverse remodeling, and the formation of neointimal after angioplasty or stenting. Additionally, vascular smooth muscle cell (VSMC) proliferation is one of major mechanisms of neointimal formation. Some studies have been conducted to investigate the molecular mechanism by which it occurs [7, 8] and have tried to suppress neointimal formation by attenuating VSMC proliferation . Therefore, observation of VSMCs proliferation and neointimal formation is an important method for studying restenosis after vascular injury. Detecting DNA synthesis in the vascular wall can indirectly reflect the VSMC proliferation in vivo.
Five-ethynyl-2'-deoxyuridine (EdU) is a nucleoside analog of thymidine which can be incorporated into DNA during active DNA synthesis. It is considered to be a novel alternative for 5-bromo-2'-deoxyuridine (BrdU) to measure DNA synthesis or S-phase synthesis of the cell cycle [10, 11]. BrdU staining requires harsh DNA denaturation (HCl, digestion with DNase or heat) to expose BrdU for detection with an anti-BrdU antibody and this action can destroy the tissue’s structures. In marked contrast, detection of EdU is based on a copper (I) catalyzed reaction [12, 13] between an azide and an alkyne, and this reaction is considerably faster. Using an azide-containing detection reagent to react with the alkyne contained in EdU can form a stable triazole ring. Moreover, the azide-containing detection reagent is significantly smaller than a BrdU antibody, so it can penetrate into a double-stranded DNA easily and can react with incorporated EdU without denaturation of the DNA. The advantage of a “click” reaction is that it makes it more convenient to observe DNA synthesis in vitro[14–17] and allows for a simple, fast protocol which produces more reproducible and reliable results. The “click” reaction involves the coupling of an azide-labeled compound and a terminal alkyne-labeled compound in the presence of copper (I) to form a stable covalent triazole ring conjugate . At the same time, some recent studies have shown that EdU can also be used to observe DNA synthesis in vivo[18–21].
A common factor in the pathogenesis restenosis after PTCA (Percutaneous transluminal coronary angioplasty) and PCI is neointimal formation, which appears following catheter balloon injury. In our previous studies, we used the carotid artery balloon injury model in obese Zucker rats, a well-established model of type II diabetes mellitus (T2DM) , as well as lean Zucker rats, to investigate the vascular response to balloon injury in diabetes [23–25]. Our studies demonstrated that this model is still valuable for investigating the mechanism of neointimal formation. Moreover, we have observed neointimal formation using the BrdU antibody detection method [24, 26]. We found that the number of BrdU-positive cells in obese Zucker rats after balloon injury was more apparent than in lean Zucker rats. However, few studies have been done on whether EdU can be used to detect DNA synthesis of neointimal formation. The Zucker obese rat and Goto-kakizaki (GK) rat are both established rat models of T2DM. The GK rat model was developed by selectively breeding non-diabetic Wistar rats for glucose intolerance over multiple generations . Compared with Zucker obese rats, GK rats are also characterized by hyperinsulinemia and mild hyperglycemia but are not obese, and have a stable and inheritable form of T2DM . And the use of GK rats is more cost-effective due to the fact that their traits are dominant. The aim of the present study is to examine whether EdU incorporation can detect DNA synthesis in the vascular neointima of GK rats and Wistar rats after balloon injury by the EdU click reaction quickly and effectively.
Male GK rats and male Wistar rats (weight, average 380 g) were used as a diabetic group and a non-diabetic group, respectively. Animals were divided into four subgroups: GK injury, GK control, Wistar injury and Wistar control. Nine rats were selected in each group. All animals and forage were purchased from SLAC Laboratory Animal Limited Company, Shanghai. GK rats were fed with a high fat diet and Wistar rats with a normal diet. Drink and food were given randomly. The room temperature was maintained at 23 to 25 degrees Celsius,with 50%-60% humidity and eight hours of light per day. All experiments were approved by the Animal Research Committee of Xuzhou Medical College (permit number XMCACUC2010-08-114).
Carotid artery balloon injury model in rats
All rats were anesthetized by intraperitoneal injection of 10% chloral hydrate (3 ml/kg body wt) diluted in double distilled water. Surgical procedures were performed by sterile surgical technique. A midline cervical incision was made to expose the left external carotid artery by blunt dissection. A 2F Fogarty balloon catheter (Edwards Lifescience Corp) was introduced from the external carotid artery into the aortic arch after the distal end of the external carotid artery was ligated. The balloon was distended with saline until a slight resistance was felt on slight traction. The balloon was gently rotated and withdrawn into the common carotid artery, then pulled back into the external carotid artery. After this procedure was repeated 3 times, the proximal end was ligated to the external carotid artery. At day 7 after balloon injury, the left common carotid arteries were completely exposed and removed after rats were euthanized by intraperitoneal injection with 10% chloral hydrate. Harvested arteries were flushed rapidly with ice-cold phosphate buffer saline (PBS). These specimens were stored in 4% paraformaldehyde diluted in PBS for 24 to 48 hours before paraffin embedding or frozen in negative 86 degrees freezer (Thermo Scientific Forma ULT).
EdU staining was conducted using Cell-LightTM EdU Kit (Rui Bo Guangzhou Biotechnology Limited Company, China), according to the manufacturer’s protocol. Paraffin sections were de-paraffinated in xylene for 10 min twice, a gradient of alcohol (100%, 95%, 85%) for 10 min, and were rinsed in deionized water for 5 min. After washing with 2 mg/ml glycine solution diluted in double distilled water for 10 min, the sections were permeablized with 0.5% Triton X-100 in PBS for 20 min, and then washed twice with PBS for 10 min each rinse. The Apollo reaction buffer liquid, catalyst, fluorescent dyes and buffer additives were dissolved in deionized water, and shaken to make the Apollo® 567 staining reaction solution. The sections were then incubated for 30 min without light. The sections were washed twice with PBS for 10 min each rinse. For subsequent DNA staining, sections were counterstained with Hoechst 33342 for 30 min away from light. The slides were then washed twice with PBS for 3 min each rinse, and observed immediately under a fluorescent microscope (magnification ×400). All the procedures were conducted at room temperature. An Olympus BX51 microscope (Olympus, Japan) was used to observe EdU-positive cells. Images of the Apollo® 567 were captured with a “red” filter set: Excitation: 550nm, Emission: 565nm, Filter: 555±15nm. Images of the Hoechst 33342 were captured with a “blue” filter set: Excitation: 350nm, Emission: 461nm, Filter: 405±15nm.
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from common carotid artery of Wistar and GK injury and control, using TRIzol® Reagent (Invitrogen life technologies) according to the manufacturer's instructions. Two micrograms of total RNA was then used for reverse transcription reaction using MMLV reverse transcriptase (Epicentre, Madison, WI). qRT-PCR was performed in an ABI PRISM7900 system (Applied Biosystems, Foster City, CA). And the gene expression of proliferating cell nuclear antigens (PCNA) and GAPDH was examined by 2×PCR master mix (Superarray). The reaction protocol included preincubation at 95°C to activate Taq DNA polymerase for 10 min, amplification of 40 cycles that was set for 10 s at 95°C, and annealing for 60 s at 60°C. The results were normalized with the housekeeping gene rat GADPH. Primer sequences were designed using software Primer 5.0 as follows. Rat PCNA forward, 5’TGAAGTTTTCTGCGAGTGGG3’; rat PCNA reverse, 5’CAGTGGAGTGGCTTTTGTGAA3’; rat GADPH forward, 5’GGAAAGCTGTGGCGTGAT-3’; rat GADPH reverse, 5’AAGGTGGAAGAATGGGAGTT3’.
Western blot analysis
The frozen common carotid tissue was homogenized in 100ul of ice-cold RIPA Lysis Buffer including 1μL PMSF (100 mM) (Beyotime Institute of Biotechnology, China) and then incubated on ice for 30 min. Samples were centrifuged at 12,000g for 10 min at 4°C. The supernatant was collected and measured for total protein content using the BCA Protein Assay kit (Beyotime Institute of Biotechnology, China). 20 μg total lysate was run on SDS-polyacrylamide gel electrophoresis and transferred onto Polyvinylidene Fluoride (PVDF) membranes. Membranes were blocked in TBST buffer containing 5% Difco TM Skim Milk (BD 232100) and incubated with the primary antibodies PCNA, Akt and p-Akt (Ser 473) (Cell Signaling Technology). Secondary antibodies were horseradish peroxidase (HRP) labeled Goat Anti-Mouse IgG (H+L), and detection was performed using enhanced chemiluminescence (ECL) (Beyotime Institute of Biotechnology, China). Measurements of band density were performed using Image J for Windows software (National Institutes of Health). Each experiment was repeated three times.
Immunohistochemistry for PCNA
Immunohistochemistry was performed using mouse monoclonal antibody to (Cell Signaling Technology) PCNA as the first antibody. SP (Streptavidin-Peroxidase) immunohistochemical assay Kit (Zhongshan Goldenbridge Biotechnology CO. LTD) was used during the staining procedure according to the manufacturer’s protocol.
Morphometry and histopathology
The arterial segments were embedded in paraffin. Sections (3~5 μm thick) were de-paraffinated and underwent hematoxylin-eosin (H&E) staining and Elastic Van Gieson (E.V.G) staining. Histomorphometric analysis was performed by individuals blinded to the treatment mode. The ratio of neointimal to medial area (N/M) was calculated using Image Pro Plus 3.0 (Media Cybernetics Corporation)
Blood glucose and lipid levels
At the time of euthanasia, blood samples were collected by cardiac puncture. Serum glucose levels, total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides were measured by the enzymatic method analysis.
Quantitative data were expressed as mean±SD. Statistical analyses was performed with the use of GraphPad Prism 5.0 (GraphPad Software Inc). Continuous variables were compared using student t tests. A value of p<0.05 was considered to be statistically significant.
EdU staining for DNA synthesis
Whether a single injection could achieve the same result was also studied. First, EdU was injected intraperitoneally (100 mg/kg) into injured GK rats at hours 4 before euthanasia. Second, EdU was injected intraperitoneally (100 mg/kg) three times at hours 18, 12 and 2 before the euthanasia. The common carotid arteries were harvested and EdU staining was conducted as described above. A greater number of EdU-positive cells were observed using multiple injections than a single one (p<0.01) (Figure 1A. i-j, o-p and D).
qRT-PCR analysis of PCNA mRNA expression
PCNA and p-Akt protein expression levels
PCNA Immunohistochemical analysis
Morphology and histopathology analysis
Blood biochemistry test
Serum glucose and lipids levels of GK and Wistar rats after injury
T2DM, a disease of carbohydrate metabolism, should be considered a vascular disease because diabetic patients have higher incidence of atherosclerosis . Metabolic and hematologic abnormalities exist in T2DM, including hyperglycemia, insulin resistance, dyslipidemia, inflammation, and thrombophilia . Diabetes itself is an independent risk factor for cardiovascular events. T2DM increases the risk for CAD by 2 to 4 times that of the overall population . CAD is more ubiquitous and has a worse prognosis in adults with diabetes mellitus than non-diabetic patients . Restenosis in patients undergoing PCI results in a lowered long term survival rate and increased rates of repeat revascularization . Moreover, the likelihood of target vessel revascularization in patients with diabetes mellitus after PCI is increased . A serial intravascular ultrasound study showed that neointimal formation was closely related to diabetes mellitus restenosis after vascular injury .
The tagging of newly synthesized DNA in cells or tissues to identify proliferation is an important experimental technique. 3H]Thymidine has been quite useful for studying DNA replication and assessing cell proliferation. However, the procedure is burdensome. BrdU staining was believed to be the “gold standard” method for detecting DNA synthesis. However, detection of BrdU requires DNA denaturation of the specimen which makes the staining process difficult and penetration of BrdU-antibody through fixed tissue is comparatively difficult. Recently, the use of EdU has been described to detect DNA replication in vivo and in vitro in animals. The application of EdU was also reported in plants and fission yeast [36, 37]. Grenier et al. determined the impact of paternal exposure to cyclophosphamide, an anticancer alkylating agent, on the formation, chromatin origin, and function of micronuclei in cleavage stage rat embryos using EdU incorporation to monitor DNA synthesis . In addition, Škalamera et al. transferred protein-coding human open reading frames (ORFs) from the Mammalian Gene Collection into lentiviral expression vector using the highly efficient Gateway recombination cloning and labeled transduced cells with EdU to detect cells progressing through S phase . The full potential of EdU in biomedical research remains to be explored.
Carotid artery injury was induced by balloon de-endothelialization in our previous study. Cell proliferation in obese Zucker rats was higher than in lean Zucker rats at day 7 after injury, and the neointimal area of obese Zucker rats was also broader than that of lean Zucker rats at day 7 after injury . Since Zucker rats and GK rats performed the same in this research. GK rats were used for some of the following research to replace Zucker rats. Time course of neointimal formation in our study was in agreement with experiments performed in our previous study . We have evaluated the effect of rosiglitazone on VSMCs proliferation in Zucker obese and lean rats after carotid artery injury with the use of BrdU incorporation to assess DNA synthesis in vivo. The rats received intraperitoneal injections of 50 mg/kg BrdU at hours 18, 12 and 2 before euthanasia. Following this procedure, the number of BrdU-labeled positive cells in the intima and media was counted . In the present day, GK and Wistar rats on the 7th day after injury were chosen to detect EdU-labeled DNA synthesis of neointimal formation and for making morphological comparisons. In the current study, we report the use of EdU to conveniently and quickly detect DNA synthesis of neointimal formation in rats after injury. EdU was injected into model rats at different doses and different injection frequencies to reach an optimal injection method for staining. Better staining results were obtained with multiple EdU injections of 100 mg/kg. This may be related to the fact that more EdU can be incorporated into proliferating cells during DNA synthesis of neointimal formation than a single injection or low doses. Attempts to obtain higher fluorescence intensity and more positive cells by injecting EdU at 200 mg/kg were unsuccessful. Along with enhancement in fluorescence intensity of EdU positive cells, the brightness of the background was simultaneously increased; however, the actual percentage of EdU positive cells remained almost the same.
PI3K/Akt signaling plays a key role in essential cellular functions such as cell growth and survival [40, 41]. Aberrant regulation of the PI3K/Akt pathway has been discovered in insulin resistant T2DM, leading to enhanced Akt activity . Activation of Akt increases translation of cell cycle-associated genes, such as cyclins and cyclin-dependent kinases. The entry of vascular cells into cell cycle plays an important role in the pathogenesis of post-angioplasty restenosis . Immediately after injury, VSMCs leave their resting state and enter the cell cycle. Arterial injury results in the proliferation and migration of VSMCs into the intimal layer of the arterial wall. The contribution of vascular proliferation to the postangioplasty restenosis is particularly important. In addition, the proliferative response is also reflected by PCNA activation, which is a well-accepted marker of cell proliferation and assists in DNA replication. In a study of rat aortic VMSCs, Akt signaling is highly activated following stimulation with platelet-derived growth factor (PDGF) . Therefore, we established an in vivo rat carotid artery injury model and determined whether neointimal SMCs exhibit activated Akt signaling. Cell proliferation involves changes at the levels of gene transcription and protein translation. In our study, cell proliferation was assessed by using immunohistochemistry staining for PCNA expression and localization to identify the actively cycling cells within the media and intima. The results showed that there were significantly more PCNA-positive VSMCs in diabetic rats than in non-diabetic rats. Using Western blot analysis we found that the protein levels of PCNA and p-Akt were both significantly increased in injured arteries, and were much higher in diabetic rats. qRT-PCR detection of PCNA mRNA levels revealed similar results, which was consistent with the detection of EdU-labeled DNA synthesis. Therefore, we indirectly and strongly confirmed the accuracy of the EdU incorporation and EdU staining by detecting PCNA expression with three distinct molecular biological methods.
To summarize, carotid artery balloon catheter injury led to cell proliferation, which was validated at the levels of PCNA and p-Akt protein as well as PCNA mRNA. And we concluded that EdU incorporation and staining was useful means for detecting DNA synthesis in the vascular neointima quickly and efficiently. Additionally, it only takes less than 2.5 hours for EdU staining, compared to 5 hours and overnight incubation for BrdU antibody detection method. In this work, we also compared the percentages of EdU-positive cells in GK and Wistar rats. We discovered that at day 7 after catheter balloon injury, DNA synthesis in the vascular neointima could be more readily observed in GK rats than in Wistar rats by intraperitoneal injections of EdU at a dose of 100 mg/kg three times. Therefore, it is recommended that a saturated dose and multiple injections can be used to obtain reliable and accurate results. In conclusion, we demonstrate the suitability of EdU incorporation and staining in GK and Wistar rats, and further probe the pathological features of diabetes mellitus by observing a higher amount of DNA synthesis in GK rats.
This work was supported by the Academic Degrees Committee and the Department of Education of Jiangsu province (grant number CXLX11-0732).
- Yang TH, Park SW, Hong MK, Park DW, Park KM, Kim YH, Han KH, Lee CW, Cheong SS, Kim JJ, Park SJ: Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol. 2005, 96 (10): 1389-1392. 10.1016/j.amjcard.2005.07.043.View ArticlePubMed
- Park DW, Flaherty JD, Davidson CJ, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ: Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in asian patients. Am J Cardiol. 2009, 103 (5): 646-652. 10.1016/j.amjcard.2008.11.012.View ArticlePubMed
- Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schömig A, Kastrati A: Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J. 2007, 154 (4): 688-693. 10.1016/j.ahj.2007.06.005.View ArticlePubMed
- Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW: Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004, 109 (19): 2273-2278. 10.1161/01.CIR.0000129767.45513.71.View ArticlePubMed
- Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators: Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005, 45 (8): 1172-1179. 10.1016/j.jacc.2004.10.075.View ArticlePubMed
- Sheehy A, Hsu S, Bouchard A, Lema P, Savard C, Guy LG, Tai J, Polyakov I: Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries. Cardiovasc Diabetol. 2012, 11: 75-10.1186/1475-2840-11-75.PubMed CentralView ArticlePubMed
- Chong ZZ, Maiese K: Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol. 2012, 11: 45-10.1186/1475-2840-11-45.PubMed CentralView ArticlePubMed
- Westerweel PE, van Velthoven CT, Nguyen TQ, den Ouden K, de Kleijn DP, Goumans MJ, Goldschmeding R, Verhaar MC: Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol. 2010, 9: 5-10.1186/1475-2840-9-5.View Article
- Zhang XW, Wang Y, Cai JB, Hou XF, Wang HG, Zou JG, Cao KJ: Downregulation of quinone reductase 2 attenuates vascular smooth muscle cells proliferation and neointimal formation in balloon injured rat carotid artery. Cell Physiol Biochem. 2012, 29 (3–4): 453-462.View ArticlePubMed
- Cappella P, Gasparri F, Pulici M, Moll J: A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A. 2008, 73 (7): 626-636.View ArticlePubMed
- Buck SB, Bradford J, Gee KR, Agnew BJ, Clarke ST, Salic A: Detection of S-phase cell cycle progression using 5-ethynyl-2′-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2′-deoxyuridine antibodies. Biotechniques. 2008, 44 (7): 927-929. 10.2144/000112812.View ArticlePubMed
- Tornøe CW, Christensen C, Meldal M: Peptidotriazoles on solid phase: [1-3]-Triazoles by regiospecific copper (i)-catalyzed 1, 3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem. 2002, 67 (9): 3057-3064. 10.1021/jo011148j.View ArticlePubMed
- Rostovtsev VV, Green LG, Fokin VV, Sharpless KB: A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ''ligation'' of azides and terminal alkynes. Angew Chem Int Ed Engl. 2002, 41 (14): 2596-2599. 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4.View ArticlePubMed
- Diermeier-Daucher S, Brockhoff G: Dynamic proliferation assessment in flow cytometry. Curr Protoc Cell Biol. 2010, Chapter 8 (Unit 8.6): 1-23.
- Diermeier-Daucher S, Clarke ST, Hill D, Vollmann-Zwerenz A, Bradford JA, Brockhoff G: Cell type specific applicability of 5-ethnyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytometry A. 2009, 75 (6): 535-546.View ArticlePubMed
- McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R: Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay. PLoS One. 2011, 6 (6): e20623-10.1371/journal.pone.0020623.PubMed CentralView ArticlePubMed
- Yu Y, Arora A, Min W, Roifman CM, Grunebaum E: EdU incorporation is an alternative non-radioactive assay to [3H]thymidine uptake for in vitro measurement of mice T-cell proliferations. J Immunol Methods. 2009, 350 (1–2): 29-35.View ArticlePubMed
- Salic A, Mitchison TJ: A chemical method for fast and sensitive detection of DNA synthesis in vivo. PNAS. 2008, 105 (7): 2415-2420. 10.1073/pnas.0712168105.PubMed CentralView ArticlePubMed
- Kaiser CL, Kamien AJ, Shah PA, Chapman BJ, Cotanche DA: 5-Ethynyl-2'-deoxyuridine labeling detects proliferating cells in the regenerating avian cochlea. Laryngoscope. 2009, 119 (9): 1770-1775. 10.1002/lary.20557.PubMed CentralView ArticlePubMed
- Zeng C, Pan F, Jones LA, Lim MM, Griffin EA, Sheline YI, Mintun MA, Holtzman DM, Mach RH: Evaluation of 5-ethynyl-2′-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 2010, 1319: 21-32.View ArticlePubMed
- Warren M, Puskarczyk K, Chapman SC: Chick embryo proliferation studies using EdU labeling. Dev Dyn. 2009, 238 (2): 944-949.PubMed CentralView ArticlePubMed
- Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat “fatty”. Endocrinology. 1972, 90 (5): 1320-1330. 10.1210/endo-90-5-1320.View ArticlePubMed
- Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Topol EJ, Lincoff AM, Wang K: Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Arterioscler Thromb Vasc Biol. 2002, 22 (10): 1598-1603. 10.1161/01.ATV.0000032676.20514.8F.View ArticlePubMed
- Wang K, Zhou Z, Zhang M, Fan L, Forudi F, Zhou X, Qu W, Lincoff AM, Schmidt AM, Topol EJ, Penn MS: Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther. 2006, 317 (1): 37-43.View ArticlePubMed
- Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation. 2003, 107 (17): 2238-2243. 10.1161/01.CIR.0000063577.32819.23.View ArticlePubMed
- Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation. 2001, 104 (7): 815-819. 10.1161/hc3301.092789.View ArticlePubMed
- Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med. 1976, 119 (1): 85-90. 10.1620/tjem.119.85.View ArticlePubMed
- El-Omar MM, Yang ZK, Phillips AO, Shah AM: Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol. 2004, 99 (2): 133-141.
- Hurst RT, Lee RW: Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med. 2003, 139 (10): 824-834.View ArticlePubMed
- Nesto RW: Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med. 2004, 116 (suppl 5A): 11S-22S.View ArticlePubMed
- Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004, 109 (7): 855-860. 10.1161/01.CIR.0000116389.61864.DE.View ArticlePubMed
- Hammound T, Tanguay JF, Bourassa MG: Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000, 36 (2): 355-365. 10.1016/S0735-1097(00)00732-4.View Article
- Smith SC, Faxon D, Cascio W, Schaff H, Gardner T, Jacobs A, Nissen S, Stouffer R: Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. Circulation. 2002, 105 (18): e165-e169. 10.1161/01.CIR.0000013957.30622.05.View ArticlePubMed
- Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, Davis BR, Holmes DR: Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with tranilast and its outcomes (PRESTO) trial. Circulation. 2004, 109 (4): 476-480. 10.1161/01.CIR.0000109693.64957.20.View ArticlePubMed
- Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study. Circulation. 1997, 95 (6): 1366-1369. 10.1161/01.CIR.95.6.1366.View ArticlePubMed
- Kotogány E, Dudits D, Horváth GV, Ayaydin F: A rapid and robust assay for detection of S-phase cell cycle progression in plant cells and tissues by using ethynyl deoxyuridine. Plant Methods. 2010, 6 (1): 5-10.1186/1746-4811-6-5.PubMed CentralView ArticlePubMed
- Hua H, Kearsey SE: Monitoring DNA replication in fission yeast by incorporation of 5-ethynyl-2'-deoxyuridine. Nucleic Acids Res. 2011, 39 (9): e60-10.1093/nar/gkr063.PubMed CentralView ArticlePubMed
- Grenier L, Robaire B, Hales BF: Paternal cyclophosphamide exposure induces the formation of functional micronuclei during the first zygotic division. PLoS One. 2011, 6 (11): e27600-10.1371/journal.pone.0027600.PubMed CentralView ArticlePubMed
- Škalamera D, Ranall MV, Wilson BM, Leo P, Purdon AS, Hyde C, Nourbakhsh E, Grimmond SM, Barry SC, Gabrielli B, Gonda TJ: A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS One. 2011, 6 (5): e20057-10.1371/journal.pone.0020057. (2011).PubMed CentralView ArticlePubMed
- Pearson RB, Thomas G: Regulation of p70S6K/p85S6K and its role in the cell cycle. Prog Cell Cycle Res. 1995, 1: 21-32.View ArticlePubMed
- Thomas G, Hall MN: Tor signaling and control of cell growth. Curr Opin Cell Biol. 1997, 9: 782-787. 10.1016/S0955-0674(97)80078-6.View ArticlePubMed
- Marx N, Duez H, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 2004, 94 (9): 1168-1178. 10.1161/01.RES.0000127122.22685.0A.View ArticlePubMed
- Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, Dzau VJ: Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol. 2001, 21 (7): 1152-1158. 10.1161/hq0701.092104.View ArticlePubMed
- Lee CS, Kwon YW, Yang HM, Kim SH, Kim TY, Hur J, Park KW, Cho HJ, Kang HJ, Park YB, Kim HS: New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Arterioscler Thromb Vasc Biol. 2009, 29 (4): 472-479. 10.1161/ATVBAHA.108.176230.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.